Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gyre Therapeutics (GYRE) Interest & Investment Income: 2009-2022

Historic Interest & Investment Income for Gyre Therapeutics (GYRE) over the last 14 years, with Dec 2022 value amounting to $717,000.

  • Gyre Therapeutics' Interest & Investment Income fell 83.33% to $47,000 in Q3 2023 from the same period last year, while for Sep 2023 it was $384,000, marking a year-over-year decrease of 30.56%. This contributed to the annual value of $717,000 for FY2022, which is 1738.46% up from last year.
  • As of FY2022, Gyre Therapeutics' Interest & Investment Income stood at $717,000, which was up 1,738.46% from $39,000 recorded in FY2021.
  • In the past 5 years, Gyre Therapeutics' Interest & Investment Income registered a high of $3.8 million during FY2018, and its lowest value of $39,000 during FY2021.
  • Over the past 3 years, Gyre Therapeutics' median Interest & Investment Income value was $717,000 (recorded in 2022), while the average stood at $628,333.
  • Per our database at Business Quant, Gyre Therapeutics' Interest & Investment Income slumped by 96.55% in 2021 and then surged by 1,738.46% in 2022.
  • Yearly analysis of 5 years shows Gyre Therapeutics' Interest & Investment Income stood at $3.8 million in 2018, then tumbled by 43.06% to $2.1 million in 2019, then crashed by 47.37% to $1.1 million in 2020, then slumped by 96.55% to $39,000 in 2021, then spiked by 1,738.46% to $717,000 in 2022.